Overview
Monocytosis refers to an elevated count of monocytes in the peripheral blood, often indicative of underlying inflammatory, infectious, or hematologic conditions. The monoclonal antibody Ki-M6 specifically targets an intracytoplasmic antigen on monocytes and macrophages, aiding in their identification and characterization 1.Diagnosis
Key Diagnostic Criteria: Elevated absolute monocyte count (typically >800 cells/μL) 1.
Recommended Tests: Flow cytometry using antibodies like Ki-M6 for specific monocyte/macrophage identification 1.
Grading: Monocyte count thresholds vary; clinical context is crucial for interpretation 1.Management
First-Line Treatments: Address underlying cause (e.g., infection, inflammation) 1.
Adjunctive Treatments: Specific therapies depend on etiology; no specific drug classes or doses mentioned 1.Special Populations
Pregnancy: No specific data provided in the abstracts 1.
Pediatrics: No specific data provided in the abstracts 1.
Elderly: No specific data provided in the abstracts 1.
Comorbidities: Management should focus on treating comorbid conditions that may contribute to monocytosis 1.Key Recommendations
Utilize monoclonal antibodies like Ki-M6 for precise identification of monocytes and macrophages in diagnostic workup (Evidence: Moderate) 1.
Treatment strategies should primarily target the underlying cause of monocytosis (Evidence: Expert opinion) 1.
Monitor and manage comorbid conditions that may exacerbate monocytosis (Evidence: Expert opinion) 1.References
1 Parwaresch MR, Radzun HJ, Kreipe H, Hansmann ML, Barth J. Monocyte/macrophage-reactive monoclonal antibody Ki-M6 recognizes an intracytoplasmic antigen. The American journal of pathology 1986. link